Leah Pierson
Biographic Data
| ID | 7990309 |
|---|---|
| NAME | Leah Pierson |
| GIVEN NAMES | Leah |
| FAMILY NAME | Pierson |
| SIGNATURE | PIERSON L |
| AFFILIATIONS | Harvard University |
| ORCID | 0000-0001-7135-8825 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Accounting for future populations in health research
The research we fund today will improve the health of people who will live tomorrow. But future people will not all benefit equally: decisions we make about what research to prioritize will predictably affect when and how much different people benefit from research. Organizations that fund health research should thus fairly account for the health needs of future populations when setting priorities. To this end, some research funders aim to alloca…
Allocation of scarce biospecimens for use in research
Hundreds of millions of rare biospecimens are stored in laboratories and biobanks around the world. Often, the researchers who possess these specimens do not plan to use them, while other researchers limit the scope of their work because they cannot acquire biospecimens that meet their needs. This situation raises an important and underexplored question: how should scientists allocate biospecimens that they do not intend to use? We argue that all…
Health Research Priority Setting
Most public and non-profit organisations that fund health research provide the majority of their funding in the form of grants. The calls for grant applications are often untargeted, such that a wide variety of applications may compete for the same funding. The grant review process therefore plays a critical role in determining how limited research resources are allocated. Despite this, little attention has been paid to whether grant review crite…
No prominent works on this page.
Allocation of scarce biospecimens for use in research
Hundreds of millions of rare biospecimens are stored in laboratories and biobanks around the world. Often, the researchers who possess these specimens do not plan to use them, while other researchers limit the scope of their work because they cannot acquire biospecimens that meet their needs. This situation raises an important and underexplored question: how should scientists allocate biospecimens that they do not intend to use? We argue that all…
Health Research Priority Setting
Most public and non-profit organisations that fund health research provide the majority of their funding in the form of grants. The calls for grant applications are often untargeted, such that a wide variety of applications may compete for the same funding. The grant review process therefore plays a critical role in determining how limited research resources are allocated. Despite this, little attention has been paid to whether grant review crite…
Accounting for future populations in health research
The research we fund today will improve the health of people who will live tomorrow. But future people will not all benefit equally: decisions we make about what research to prioritize will predictably affect when and how much different people benefit from research. Organizations that fund health research should thus fairly account for the health needs of future populations when setting priorities. To this end, some research funders aim to alloca…
Health Systems, Economic Evaluations, Quality of Life (3 works) · Political science (3 works) · Business (2 works) · Ethics in Clinical Research (2 works) · Healthcare cost, quality, practices (2 works) · Medicine (2 works) · Public relations (2 works) · Allocator (1 work) · Biobank (1 work) · Bioinformatics (1 work)